MODERATE TO SEVERE ATOPIC DERMATITIS
Clinical trials for MODERATE TO SEVERE ATOPIC DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE ATOPIC DERMATITIS trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE ATOPIC DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot could tame tough eczema
Disease control Recruiting nowThis study tests an experimental injection called SHR-1819 in 200 adults with moderate-to-severe atopic dermatitis (a type of eczema). The goal is to see if it safely reduces skin redness, swelling, and itching. Participants will receive either the drug or a placebo, and their pr…
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 26, 2026 10:58 UTC
-
New shot could tame tough eczema in phase 2 trial
Disease control Recruiting nowThis study tests an experimental drug called SHR-1905 for adults with moderate-to-severe atopic dermatitis (eczema). About 75 participants will receive either the drug or a placebo injection to see if it safely reduces skin redness, itching, and rash. The main goal is to check if…
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
New eczema drug TRB-061 enters first human safety trials
Symptom relief Recruiting nowThis early-stage study tests a new medicine called TRB-061 for people with moderate-to-severe atopic dermatitis (eczema). The goal is to check if the drug is safe and how it moves through the body. The study includes healthy volunteers and patients with eczema, who receive either…
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE1 • Sponsor: TRex Bio, Inc. • Aim: Symptom relief
Last updated May 26, 2026 11:04 UTC
-
New eczema drug enters first human tests
Symptom relief Recruiting nowThis early-stage study tests a new drug called SYX-5219 in healthy volunteers and people with moderate to severe atopic dermatitis (eczema). The main goal is to check safety and how the drug moves through the body. Up to 149 participants will receive either the drug or a placebo …
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE1 • Sponsor: Sitryx Therapeutics Ltd • Aim: Symptom relief
Last updated May 26, 2026 11:03 UTC